Article
Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 Nov 2012
Schildhaus Hans-Ulrich, Heukamp Lukas C, Merkelbach-Bruse Sabine, Riesner Katharina, Schmitz Katja, Binot Elke, Paggen Ellen, Albus Kerstin, Schulte Wolfgang, Ko Yon-Dschun, Schlesinger Andreas, Ansén Sascha, Engel-Riedel Walburga, Brockmann Michael, Serke Monika, Gerigk Ulrich, Huss Sebastian, Göke Friederike, Perner Sven, Hekmat Khosro, Frank Konrad F, Reiser Marcel, Schnell Roland, Bos Marc, Mattonet Christian, Sos Martin, Stoelben Erich, Wolf Jürgen, Zander Thomas, Buettner Reinhard
Abstract excerpt
We recently reported fibroblast growth factor receptor-type 1 (FGFR1) amplification to be associated with therapeutically tractable FGFR1 dependency in squamous cell lung cancer. This makes FGFR1 a novel target for directed therapy in these tumors. To reproducibly identify patients for clinical studies, we developed a standardized reading and evaluation strategy for FGFR1 fluorescence in-situ hybridization (FISH)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
